Patients in the Hahnemann University Hospital Liver Disease Transplant Program receive advanced care from a highly respected team of specialists offering these advantages:
A successful liver transplant can offer patients with liver disease a return to a full and active lifestyle for many years to come. Usually, they will be free of the weakness, fatigue, confusion and lack of appetite that plagued them prior to the transplant. The transplant team at Hahnemann University Hospital is committed to providing the benefits of liver transplantation to all appropriate patients interested in exploring this option. Our goal is to assist patients through the evaluation process, get them placed on the national waitlist and then complete transplantation in the shortest possible time with the best possible outcome. We take pride in the excellent service we provide. Physicians and staff communicate directly with you and there is always a member of the transplant team on-call for after hour concerns.
You may be a candidate for a liver transplant if you have been diagnosed with acute or fulminante liver failure or a chronic liver disease, such as Hepatitis B, Hepatitis C, hepatocellular carcinoma (liver cancer), autoimmune liver disease, or alcoholic or non-alcoholic liver disease. Part of the evaluation process will be to determine your MELD score, which is derived from laboratory tests and predicts the severity of liver failure.
This dedicated unit provides focused care to patients with advanced liver disease who require in-patient hospitalization, including those being evaluated for or awaiting liver transplantation or post-transplant care. Hahnemann’s experienced liver failure team, including hepatologists, transplant surgeons and other specialists, partner with specially trained nursing staff to ensure a high level of care for these complex patients. Advanced liver disease can be the result of chronic or acute liver disorders such as hepatitis, hepatocellular carcinoma, alcoholic or non-alcoholic fatty liver, or autoimmune liver diseases.
In addition, the unit will allow for successful execution of ongoing research and clinical trials being conducted by the medical staff and research team at Hahnemann University Hospital.
Hahnemann University Hospital's Liver Disease Transplant Program has satellite offices throughout the Delaware Valley.
Click below to learn more about our liver transplant services team.
Chief, Center for Multi-Organ Transplantation
Professor and Vice Chair, Department of Surgery, Drexel University College of Medicine
Dr. Reich specializes in liver and kidney transplantation, complex liver surgery, treatments for liver tumors, and transplantation of high-risk patients. He has conducted internationally recognized research into safe use of extended criteria donor organs, bioartificial liver support, and healthcare performance improvement.
Dr. Reich serves in numerous national leadership roles, including as member of the Board of Directors and Region 2 Councilor for the United Network for Organ Sharing (UNOS), chair of the Quality and Pay Reform MACRA Task Force and past chair of the Standards Committee and of the Legislative Committee of the American Society of Transplant Surgeons, and Member of the Editorial Board of Liver Transplantation.
Dr. Reich is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. He is a
Philadelphia Magazine Top Doc consecutively since 2010.
Gary S. Xiao, MD, FACS
Director, Liver Transplant Program
Assistant Professor of Surgery, Drexel University College of Medicine
Dr. Xiao specializes in liver and kidney transplantation and Hepato-Pancreato- Biliary surgery. He is highly experienced in laparoscopic and open liver resection, liver tumor ablation and pancreatic surgery and resection, especially in very complicated and challenging cases. Dr. Xiao is a United Network for Organ Sharing-certified laparoscopic living donor nephrectomy surgeon. He is an American Society of Transplant Surgeons certified liver, kidney and pancreas transplant surgeon. He serves on the Regulatory and Reimbursement Committee of the American Society of Transplant Surgeons. Dr. Xiao is also certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. He has conducted pivotal clinical and translational research on liver cancer, and published and lectured internationally.
Stephen R. Guy, MD, FACS
Director, Kidney Transplant Program
Associate Professor, Drexel University College of Medicine
Dr. Guy is a kidney and liver transplant surgeon with over fifteen years of experience specializing in multi-organ transplantation. He was instrumental in developing laparoscopic living donor nephrectomy for kidney transplantation, a minimally invasive surgery for individuals donating a kidney. Dr. Guy is also experienced in transplantation of high-risk patients, long-term healthcare following transplantation and in pancreas, liver and laparoscopic surgery.
Dr. Guy is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons.
The transplant hepatologist, or liver specialist, monitors all non-surgical aspects of patient care. This includes performing examinations, assessing test results and adjusting medication as needed.
Santiago J. Munoz, MD, FACP, FACG
Chief, Hepatology and Liver Failure Unit
Medical Director, Liver Transplant Program
Dr. Munoz has been practicing hepatology in the Philadelphia area for nearly three decades. He specializes in the diagnosis and treatment of benign and malignant liver diseases and has a focus on liver failure patients. Before coming to Hahnemann, Dr. Munoz developed and led several liver transplant programs in the Philadelphia area. In addition to being certified by the American Board of Internal Medicine, Dr. Munoz is certified by the Subspecialty Board of Gastroenterology and Transplant Hepatology. He is also frequently named among
Philadelphia Magazine’s annual list of
Andrés R. Riera, MD
Hepatologist, Liver Transplant Program
Assistant Professor of Medicine, Drexel University College of Medicine
Dr. Riera’s focus is on the treatment of advanced liver disease and its complications, with a particular interest in hepatocellular carcinoma. He has participated in numerous scientific research studies specific to advancements in treating end stage liver disease. Dr. Riera completed his medical degree at the J.M. Vargas School of Medicine at the Central University of Venezuela and his residency in Internal Medicine and fellowship in Hepatology at Hahnemann University Hospital, Drexel University College of Medicine. He is certified by the American Board of Internal Medicine and fluent in Spanish and English.
Our team is highly experienced in caring for patients with tumors and other diseases of the liver, bile ducts and pancreas. We provide:
We offer the full spectrum of diagnostic and therapeutic care, including:
To schedule an appointment with us, please call The Center for Liver Disease at Hahnemann University Hospital at
To schedule an appointment with The Liver Transplant Program at Hahnemann University Hospital, please call us at 215-762-3900.
Read success stories from transplant patients at Hahnemann.